SCHEMBL13613956

SCHEMBL13613956

COC(=O)Cc1ccc(-c2cc(O)c3c(c2)C(C)(C)CCC3N(C)C2CC2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
GAA P10253 3/20 0.37
GFER P55789 1/20 0.37
MAPT P10636 3/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
EPHX2 P34913 1/20 0.32
PDK2 Q15119 1/20 0.32
HSP90AB1 P08238 1/20 0.32
RAB9A P51151 3/20 0.31
NPC1 O15118 2/20 0.31
RARB P10826 3/20 0.31
RARG P13631 3/20 0.31
RARA P10276 2/20 0.31
CYP26B1 Q9NR63 1/20 0.31
CHEK1 O14757 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13613918 0.87 RXRA (0.36) ALDH1A1GAAGFERMAPTRXRA
SCHEMBL13606662 0.86 GAA (0.35) ALDH1A1GAAGFERMAPTCYP4F2
SCHEMBL14524779 0.86 RARA (0.34) ALDH1A1GAAMAPTRXRARXRB
SCHEMBL13613947 0.82 RXRA (0.43) ALDH1A1GAARXRARXRBRXRG
SCHEMBL13613957 0.81 RARG (0.35) RARBRARGRARA
SCHEMBL4511698 0.79 ACACB (0.38) ALDH1A1GAAGFERMAPTCYP4F2
SCHEMBL13613856 0.78 RXRA (0.43) GAARXRARXRBRXRGCYP26B1
SCHEMBL13613911 0.77 RXRA (0.45) RXRARXRBRXRGCYP26B1
SCHEMBL13613909 0.76 RXRA (0.41) GAARXRARXRBRXRGCYP26B1
SCHEMBL13613893 0.76 RXRA (0.41) RXRARXRBRXRGRARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7638648-B2 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same ALLERGAN INC. (US) 2009-12-29 US disclosed
US-20080004455-A1 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same ALLERGAN, INC. (US) 2008-01-03 US disclosed
US-7226951-B2 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same ALLERGAN, INC. (US) 2007-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004455-A1 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same CYP1A2, CYP2A7, CYP3A7 ALDH1A1 96/4885GAA 904/4885GFER 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.